drug
as of 2026-07-01Blonanserin
MeSH C079310
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
2
Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients
NCT03784222Phase 4Terminated
Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone
NCT01516424Phase 3Completed
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
indication
KOL
Xin Yu, MD.
personKOL score —
Niufan Gu, MD
personKOL score —